AsclepiX Therapeutics nabs $35m Series A

New Jersey-based AsclepiX Therapeutics, Inc, a biopharmaceutical company, has raised $35 million in Series A financing.

New Jersey-based AsclepiX Therapeutics, Inc, a biopharmaceutical company, has raised $35 million in Series A financing. Perceptive Xontogeny Venture Fund led the round.

Source: Press Release